Eqis Capital Management Inc. Boosts Position in Mettler-Toledo International Inc. (MTD)
Eqis Capital Management Inc. increased its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 7.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 897 shares of the medical instruments supplier’s stock after purchasing an additional 66 shares during the quarter. Eqis Capital Management Inc.’s holdings in Mettler-Toledo International were worth $648,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the stock. FMR LLC raised its holdings in shares of Mettler-Toledo International by 4.8% in the 4th quarter. FMR LLC now owns 2,314,447 shares of the medical instruments supplier’s stock worth $1,309,005,000 after purchasing an additional 107,049 shares during the period. BlackRock Inc. raised its holdings in shares of Mettler-Toledo International by 2.2% in the 4th quarter. BlackRock Inc. now owns 1,709,674 shares of the medical instruments supplier’s stock worth $966,960,000 after purchasing an additional 36,558 shares during the period. WCM Investment Management LLC raised its holdings in shares of Mettler-Toledo International by 5.6% in the 4th quarter. WCM Investment Management LLC now owns 1,497,423 shares of the medical instruments supplier’s stock worth $846,912,000 after purchasing an additional 79,567 shares during the period. Fiera Capital Corp raised its holdings in shares of Mettler-Toledo International by 4.2% in the 4th quarter. Fiera Capital Corp now owns 704,726 shares of the medical instruments supplier’s stock worth $398,579,000 after purchasing an additional 28,271 shares during the period. Finally, Baillie Gifford & Co. raised its holdings in shares of Mettler-Toledo International by 5.3% in the 4th quarter. Baillie Gifford & Co. now owns 627,108 shares of the medical instruments supplier’s stock worth $354,680,000 after purchasing an additional 31,282 shares during the period. 95.69% of the stock is currently owned by institutional investors.
MTD has been the subject of a number of recent research reports. Evercore ISI lowered shares of Mettler-Toledo International from an “in-line” rating to an “underperform” rating in a research note on Thursday, January 3rd. Bank of America lowered shares of Mettler-Toledo International from a “buy” rating to a “neutral” rating and set a $546.04 price objective for the company. in a research note on Thursday, January 3rd. ValuEngine lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Friday, January 4th. Finally, Zacks Investment Research lowered shares of Mettler-Toledo International from a “hold” rating to a “sell” rating in a research note on Tuesday, January 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $650.67.
Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, February 7th. The medical instruments supplier reported $6.85 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.11. Mettler-Toledo International had a net margin of 17.46% and a return on equity of 94.57%. The business had revenue of $817.92 million during the quarter, compared to analyst estimates of $807.58 million. During the same period in the previous year, the business earned $5.97 EPS. Mettler-Toledo International’s revenue was up 5.1% compared to the same quarter last year. Sell-side analysts forecast that Mettler-Toledo International Inc. will post 22.67 EPS for the current year.
In other news, Director Wah-Hui Chu sold 1,000 shares of the business’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $692.50, for a total transaction of $692,500.00. Following the completion of the transaction, the director now directly owns 3,854 shares in the company, valued at approximately $2,668,895. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Thomas P. Salice sold 1,300 shares of the business’s stock in a transaction on Monday, February 25th. The shares were sold at an average price of $685.50, for a total transaction of $891,150.00. Following the transaction, the director now owns 5,894 shares of the company’s stock, valued at $4,040,337. The disclosure for this sale can be found here. Insiders have sold a total of 150,995 shares of company stock valued at $100,997,450 over the last 90 days. Company insiders own 3.50% of the company’s stock.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.
Featured Article: Gap Up Stocks
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.